Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.
Masetti M, Acquaviva G, Visani M, Tallini G, Fornelli A, Ragazzi M, Vasuri F, Grifoni D, Di Giacomo S, Fiorino S, Lombardi R, Tuminati D, Ravaioli M, Fabbri C, Bacchi-Reggiani ML, Pession A, Jovine E, de Biase D.
Masetti M, et al. Among authors: ragazzi m.
Cancer Biomark. 2018 Feb 6;21(2):323-334. doi: 10.3233/CBM-170464.
Cancer Biomark. 2018.
PMID: 29103024